Sort
172,184 grants matching “inflammation”
Durable Alteration of the Human Immune system after Infection or Immunotherapy
$2,446,152Raymond T Chung · Massachusetts General Hospital · U19 · FY2024 · AI
Development of Novel Mycolytic Therapies for Lung Disease
$2,446,101David B Peden · Univ Of North Carolina Chapel Hill · P01 · FY2018 · HL
Mechanisms of Ethnic/Racial Differences in Lung Cancer Due to Cigarette Smoking
$2,444,787Stephen S Hecht · University Of Minnesota · P01 · FY2017 · CA
Neuroactive steroids as novel psychiatric treatments: mechanistic studies
$2,444,687Steven J Mennerick · Washington University · P50 · FY2022 · MH
Neutrophil lineage in inflammation
$2,444,008Sergio Daniel Catz · Scripps Research Institute, The · P01 · FY2025 · HL
Hematopoiesis in cardiovascular disease
$2,443,825Matthias Nahrendorf · Massachusetts General Hospital · P01 · FY2023 · HL
Hematopoiesis in cardiovascular disease
$2,443,825Matthias Nahrendorf · Massachusetts General Hospital · P01 · FY2022 · HL
Diabetes and Periodontics Trial - Administrative Center/Study Chair
$2,443,149Steven P Engebretson · State University New York Stony Brook · U01 · FY2010 · DE
Applying Bioinformatics to Research in Immune, Muscle, and Bone Diseases
$2,442,797Hong-Wei Sun · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIC · FY2024 · AR
Nutrition and Superfund Chemical Toxicity
$2,442,381Bernhard Hennig · University Of Kentucky · P42 · FY2015 · ES
Nutrition and Superfund Chemical Toxicity
$2,442,381Bernhard Hennig · University Of Kentucky · P42 · FY2014 · ES
Nutrition and Superfund Chemical Toxicity
$2,442,381Bernhard Hennig · University Of Kentucky · P42 · FY2018 · ES
Mitochondrial Quality in Cardioprotection: Overcoming Co-Morbidities
$2,442,081Roberta A. Gottlieb · Cedars-Sinai Medical Center · P01 · FY2017 · HL
Advancing Transplantation Outcomes in Children
$2,441,871David Michael Briscoe · Boston Children'S Hospital · U01 · FY2022 · AI
Validation of Biomarkers of Small Vessel Injury in VCID
$2,441,705Gary Allen Rosenberg · University Of New Mexico Health Scis Ctr · UF1 · FY2021 · NS
Nutrition and Superfund Chemical Toxicity
$2,441,545Bernhard Hennig · University Of Kentucky · P42 · FY2019 · ES
Mitochondrial Quality in Cardioprotection: Overcoming Co-Morbidities
$2,441,087Roberta A. Gottlieb · Cedars-Sinai Medical Center · P01 · FY2016 · HL
Exploring the biology of persistent type 2 airway niches in asthma
$2,441,079John V Fahy · University Of California, San Francisco · P01 · FY2019 · HL
Pre- and Postnatal Exposure Periods for Child Health: Common Risks and Shared Mechanisms
$2,440,263Thomas G O'Connor · University Of Rochester · UH3 · FY2018 · OD
Hyperbaric Oxygen Therapy for Ulcerative Colitis Patients Hospitalized for Moderate to Severe Flares: A Phase 3 Multi-Center, Randomized, Double-Blind, Sham-Controlled Trial
$2,439,584Parambir Singh Dulai · Northwestern University At Chicago · U01 · FY2023 · DK
Studies of Physiologic and Pathologic Platelet Plug Formation
$2,439,527Lawrence F Brass · University Of Pennsylvania · P01 · FY2023 · HL
Exploring the biology of persistent type 2 airway niches in asthma
$2,438,988John V Fahy · University Of California, San Francisco · P01 · FY2020 · HL
Exploring the biology of persistent type 2 airway niches in asthma
$2,438,988John V Fahy · University Of California, San Francisco · P01 · FY2021 · HL
Exploring the biology of persistent type 2 airway niches in asthma
$2,438,988John V Fahy · University Of California, San Francisco · P01 · FY2022 · HL
Exploring the biology of persistent type 2 airway niches in asthma
$2,438,988John V Fahy · University Of California, San Francisco · P01 · FY2023 · HL